Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 677–678 | Cite as

ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients

  • Marieke E. M. van der Noordaa
  • Marie-Jeanne T. F. D. Vrancken PeetersEmail author
ASO Author Reflections



Marieke van der Noordaa and Marie-Jeanne Vrancken Peeters have no conflicts of interest to disclose.


  1. 1.
    Dominici LS, Negron Gonzalez VM, Buzdar AU, et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010;116(12):2884–2889.CrossRefGoogle Scholar
  2. 2.
    van Nijnatten TJ, Schipper RJ, Lobbes MB, Nelemans PJ, Beets-Tan RG, Smidt ML. The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(10):1278–1287.CrossRefGoogle Scholar
  3. 3.
    van der Noordaa MEM, van Duijnhoven FH, Straver ME, et al. Major reduction in axillary lymph node dissections after neoadjuvant systemic therapy for node-positive breast cancer by combining PET/CT and the MARI procedure. Ann Surg Oncol. 2018;25(6):1512–1520.CrossRefGoogle Scholar
  4. 4.
    Koolen BB, Donker M, Straver ME, et al. Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy. Br J Surg. 2017;104(9):1188–1196.CrossRefGoogle Scholar
  5. 5.
    Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378–382.CrossRefGoogle Scholar
  6. 6.
    Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072–8.CrossRefGoogle Scholar
  7. 7.
    Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol. 2017;3(4):549–555.CrossRefGoogle Scholar
  8. 8.
    van der Noordaa MEM, van Duijnhoven FH, Loo CE, et al. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment). Breast. 2018;40:76–81.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Marieke E. M. van der Noordaa
    • 1
  • Marie-Jeanne T. F. D. Vrancken Peeters
    • 1
    Email author
  1. 1.Department of Surgical OncologyNetherlands Cancer Institute–Antoni van LeeuwenhoekAmsterdamThe Netherlands

Personalised recommendations